Sacituzumab tirumotecan

• immunoglobulin g1 anti human tumor associated calcium signal transducer 2 human mus musculus monoclonal hrs7 γ1 chain disulfide with human mus musculus monoclonal hrs7 κ chain dimer reduced s 5 6 1 34s 38 amino 34 4 4s 4 ethyl 3 4 12 14 tetrahydro 11 2 1 methylethyl methylsulfonyl amino ethyl 3 14 dioxo 1h pyrano 3 4 6 7 indolizino 1 2 b quinolin 4 yl oxy carbonyl oxy methyl phenyl amino carbonyl 28 32 dioxo 3 6 9 12 15 18 21 24 30 nonaoxa 27 33 diazaoctatriacont 1 yl 1h 1 2 3 triazol 4 yl methyl amino 6 oxo 1 hexyn 1 yl 2 pyrimidinyl l cysteine
• immunoglobulin g1 kappa anti homo sapiens tacstd2 tumor associated calcium signal transducer 2 membrane component chromosome 1 surface marker 1 m1s1 gastrointestinal tumor associated antigen ga7331 pancreatic carcinoma marker protein ga733 1 epithelial glycoprotein 1 egp 1 trophoblast antigen 2 cell surface glycoprotein trop 2 trop2 humanized monoclonal antibody conjugated to the topoisomerase i inhibitor tirumotecan
• immunoglobulin g1 kappa anti homo sapiens tacstd2 tumor associated calcium signal transducer 2 membrane component chromosome 1 surface marker 1 m1s1 gastrointestinal tumor associated antigen ga7331 pancreatic carcinoma marker protein ga733 1 epithelial glycoprotein 1 egp 1 trophoblast antigen 2 cell surface glycoprotein trop 2 trop2 humanized monoclonal antibody conjugated to the topoisomerase i inhibitor tirumotecan gamma1 heavy chain humanized 1 451 vh homo sapiens ighv7 4 1 02 85 70 ighd ighj4 01 86 7 t122 s 115 cdr imgt 8 8 14 26 33 51 58 97 110 1 121 homo sapiens ighg1 03 g1m3 ng1m1ch1 r120 ch3 e12 m14 ch1 r120 218 122 219 hinge 220 234 ch2 235 344 ch3 e12 360 m14 362 345 449 chs 450 451 122 451 224 214 disulfide with kappa light chain humanized 1 214 v kappa homo sapiens igkv1 9 01 82 2 igkj4 01 91 7 g120 a 100 cdr imgt 6 3 9 27 32 50 52 89 97 1 107 homo sapiens igkc 01 km3 a45 1 153 v101 191 108 214 dimer 230 230 233 233 bisdisulfide produced in chinese hamster ovary cho cells cell line cho s glycoform alfa substituted at the sulfur atoms of eight l cysteinyl residues with 5 6 1 34s 38 amino 34 4 4s 4 ethyl 11 2 n propan 2 yl methanesulfonamido ethyl 3 14 dioxo 3 4 12 14 tetrahydro 1h pyrano 3 4 6 7 indolizino 1 2 b quinolin 4 yl oxy carbonyl oxy methyl phenyl carbamoyl 28 32 dioxo 3 6 9 12 15 18 21 24 30 nonaoxa 27 33 diazaoctatriacontan 1 yl 1h 1 2 3 triazol 4 yl methyl amino 6 oxohex 1 yn 1 yl pyrimidin 2 yl tirumotecan groups
• Immunoglobulin G1-kappa, anti-[Homo sapiens TACSTD2 (tumor-associated calcium signal transducer 2, membrane component chromosome 1 surface marker 1, M1S1, gastrointestinal tumor-associated antigen GA7331, pancreatic carcinoma marker protein GA733-1, epithelial glycoprotein-1, EGP-1, trophoblast antigen-2, cell surface glycoprotein Trop-2, TROP2)], humanized monoclonal antibody, conjugated to the topoisomerase I inhibitor tirumotecan
• immunoglobulin G1-kappa, anti-[Homo sapiens TACSTD2 (tumor-associated calcium signal transducer 2, membrane component chromosome 1 surface marker 1, M1S1, gastrointestinal tumor-associated antigen GA7331, pancreatic carcinoma marker protein GA733-1, epithelial glycoprotein-1, EGP-1, trophoblast antigen-2, cell surface glycoprotein Trop-2, TROP2)], humanized monoclonal antibody; conjugated to the topoisomerase I inhibitor tirumotecan; gamma1 heavy chain humanized (1-451) [VH (Homo sapiens IGHV7-4-1*02 (85.70%) -(IGHD)-IGHJ4*01 (86.7%) T122>S (115), CDR-IMGT [8.8.14] (26-33.51-58.97-110)) (1-121) -Homo sapiens IGHG1*03, G1m3, nG1m1CH1 R120, CH3 E12, M14 (CH1 R120 (218) (122-219), hinge (220-234), CH2 (235-344), CH3 E12 (360), M14 (362) (345-449), CHS (450-451)) (122-451)], (224-214')- disulfide with kappa light chain humanized (1'-214') [V-KAPPA (Homo sapiens IGKV1-9*01 (82.2%) -IGKJ4*01 (91.7%) G120>A (100), CDR-IMGT [6.3.9] (27'-32'.50'-52'.89'-97')) (1'-107') -Homo sapiens IGKC*01, Km3, A45.1 (153'), V101 (191') (108'-214')]; dimer (230-230":233-233")-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-S, glycoform alfa; substituted at the sulfur atoms of eight L-cysteinyl residues with 5-(6-{[(1-{(34S)-38-amino-34-[(4-{[({[(4S)-4-ethyl-11-{2-[N-(propan-2-yl)methanesulfonamido]ethyl}-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl]oxy}carbonyl)oxy]methyl}phenyl)carbamoyl]-28,32-dioxo-3,6,9,12,15,18,21,24,30-nonaoxa-27,33-diazaoctatriacontan-1-yl}-1H-1,2,3-triazol-4-yl)methyl]amino}-6-oxohex-1-yn-1-yl)pyrimidin-2-yl (tirumotecan) groups
• Immunoglobulin G1, anti-(human tumor-associated calcium signal transducer 2) (human-Mus musculus monoclonal hRS7 γ1-chain), disulfide with human-Mus musculus monoclonal hRS7 κ-chain, dimer, reduced, S-[5-[6-[[[1-[(34S)-38-amino-34-[[[4-[[[[[(4S)-4-ethyl-3,4,12,14-tetrahydro-11-[2-[(1-methylethyl)(methylsulfonyl)amino]ethyl]-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-4-yl]oxy]carbonyl]oxy]methyl]phenyl]amino]carbonyl]-28,32-dioxo-3,6,9,12,15,18,21,24,30-nonaoxa-27,33-diazaoctatriacont-1-yl]-1H-1,2,3-triazol-4-yl]methyl]amino]-6-oxo-1-hexyn-1-yl]-2-pyrimidinyl]-L-cysteine
• mk 2870
• Mk-2870
• mk2870
• MK2870
• sacituzumab tirumotecan
• Sacituzumab tirumotecan
• Sacituzumab Tirumotecan
• Sacituzumab Tirumotecan (Observational Cohort)
• Sacituzumab tirumotecan (sac-TMT)
• Sacituzumab Tirumotecan (sac-TMT)
• Sacituzumab Tirumotecan (Sac-TMT)
• Sacituzumab Tirumotecan (SKB264)
• sacituzumab tirumotecan [INN]
• SACITUZUMAB TIRUMOTECAN [USAN]
• Sacituzumab tirumotecan [WHO-DD]
• sacituzumab tirumotecan inn
• sacituzumab tirumotecan usan
• sacituzumab tirumotecan who dd
• skb 264

And 4 more, listed on the interactive page.